News | Heart Valve Technology

Lenox Hill Hospital is the first hospital in New York City to successfully implant Abbott’s Tendyne transcatheter mitral valve replacement (TMVR) system to replace a leaky heart valve. The procedure was performed as part of a national clinical trial testing the safety and efficacy of the device as an alternative to invasive open heart surgery.

Home January 28, 2019
Home
News | Drug-Eluting Balloons

Philips announced the latest pooled analysis of patient-level data of over 2,300 patients treated with Philips’ Stellarex Drug-Coated Balloon (DCB) in above-the-knee (ATK) studies, which the company said reinforces the strong safety profile of Stellarex. The independent, third-party pooled analysis demonstrated low mortality rates through three years after the treatment with no device-related deaths.

Home January 28, 2019
Home
Videos | Cardiac Imaging

DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displayed on the ...

Home January 26, 2019
Home
The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since 2003 ...

Home January 25, 2019
Home
News | Artificial Intelligence

January 25, 2019 — Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad ...

Home January 25, 2019
Home
News | Peripheral Artery Disease (PAD)

January 25, 2019 — Profusa announced promising clinical data from two studies evaluating the company's Lumee Oxygen ...

Home January 25, 2019
Home
Videos | Heart Valve Technology

Joe Cleveland, M.D., professor of cardiothoracic surgery, at the University of Colorado Hospital, offers a cardiac ...

Home January 25, 2019
Home
News | Peripheral Artery Disease (PAD)

A new report in the Journal of Vascular Surgery chronicles a multi-site randomized controlled trial comparing treatment efficacy, functional outcomes, cost effectiveness and quality of life for various treatments for critical limb ischemia (CLI). The trial will enroll 2,100 patients suffering from CLI, a debilitating and increasingly common manifestation of peripheral arterial disease (PAD) that puts patients at high risk for leg amputation, cardiovascular complications and death.

Home January 23, 2019
Home
News | Cardiac Diagnostics

Researchers have identified another reason to limit red meat consumption: high levels of a gut-generated chemical called trimethylamine N-oxide (TMAO) that is also linked to heart disease. Scientists found that people who eat a diet rich in red meat have triple the TMAO levels of those who eat a diet rich in either white meat or mostly plant-based proteins, but discontinuation of red meat eventually lowers those TMAO levels.

Home January 23, 2019
Home
An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal. Thrombectomy is also referred to as embolectomy.
Feature | Thrombectomy Devices | Dave Fornell, Editor

Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but declined ...

Home January 22, 2019
Home
News | Stents

The rise cardiovascular disease has been instrumental in fueling the coronary stent market share in the past few years ...

Home January 22, 2019
Home
News | Cardiovascular Ultrasound

January 21, 2019 – Medical experts have released “Guidelines for Performing a Comprehensive Transthoracic ...

Home January 21, 2019
Home
News | Cardiac Diagnostics

Meat-free athletes have already proven the performance-boosting power of a plant-based diet. Now, “Plant-Based Diets for Cardiovascular Safety and Performance in Endurance Sports,” a new scientific review published in the journal Nutrients1 adds further evidence that plant-based athletes benefit from improvements in heart health, performance and recovery.

Home January 21, 2019
Home
Seth Worley, M.D., senior consultant, section of cardiac electrophysiology, MedStar Heart and Vascular Institute, developed tools and techniques to optimize transvenous left ventricular (LV) lead implantation, including the I-CRT approach. Here he holds the tools that he personally developed for left ventricular lead implantation to treat heart failure. Photo courtesy of MedStar Heart and Vascular Institute at MedStar Washington Hospital Center.
Feature | EP Lab | Matthew S. McKillop, M.D., FACC, FHRS, and Seth J. Worley, M.D.

Interventional cardiac resynchronization therapy (I-CRT) describes the repurposing of a set of tools and techniques ...

Home January 21, 2019
Home
Technology

Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, a new ablation catheter designed to help physicians accurately and effectively treat atrial fibrillation (AFib). The approval further expands Abbott's portfolio of cardiac ablation tools that integrate with the company's EnSite Precision cardiac mapping system to help physicians develop more precise images of the heart during cardiac ablation procedures.

Home January 21, 2019
Home
Subscribe Now